Emergency room visits attributed to popular weight loss drugs such as Ozempic and Wegovy remain quite rare overall, but do ...

Danish drugmaker Novo Nordisk is looking at an early launch of its blockbuster weight-loss drug Wegovy in India to better ...

The Centers for Medicare and Medicaid Services recently announced—without explanation—that it would not proceed with a ...

A popular weight-loss drug used by celebrities overseas has been approved by New Zealand’s medicine regulatory body, with its ...

While gastrointestinal issues are the most common side effects, a recent study by the University of British Columbia linked ...

Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through ...

The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...

Obesity and diabetes drugs, particularly semaglutides like Wegovy and Ozempic, may reduce a person’s risk of dementia, a new ...

Researchers believe that Semaglutide shows promise in cutting the risk of conditions that could impair memory and thought ...

A groundbreaking study from the University of British Columbia has revealed a potentially disturbing side effect for those ...

The buy now, pay later model has taken off. Experts say BNPL can be useful when used responsibly, but shoppers should be careful not to overspend.

The use of weight loss treatments like Ozempic and Wegovy has skyrocketed in the Western world. But as more people turn to these treatments, which mimic the appetite-suppressing hormone GLP-1 ...